ÂÜÀòÂÒÂ×

Karen From has more than 25 years of experience in the pharmaceutical industry. She has worked at AstraZeneca since 1997 and has experience in both early and late development projects, in-licensing, regulatory interactions and launching large products. Since 2019, she is the Global Franchise Head for Forxiga, which is AstraZeneca¡¯s second largest product with indications in diabetes, heart failure and kidney failure. In this role, she is globally responsible for the strategic leadership of development, commercialization, and production.